Covid-19 News

    Sino-Canadian Skullduggery? Canada Sent Dangerous Henipah Virus to China In 2019, and Early Wuhan Samples Show Modified Version of This Pathogen


    Sino-Canadian Skullduggery? Canada Sent Dangerous Henipah Virus to China In 2019, and Early Wuhan Samples Show Modified Version of This Pathogen
    The first part of our saga begins with an article from August 9, 2019 in The Scientist, “Questions Surround Canadian Shipment of Deadly Viruses to China.”
    trialsitenews.com


    The first part of our saga begins with an article from August 9, 2019 in The Scientist, “Questions Surround Canadian Shipment of Deadly Viruses to China.” We learn that Canada’s National Microbiology Laboratory (NML) sent both Ebola and Henipah viruses to Beijing March 31 of 2019, and this is raising concerns from biochemical war experts who believe China could use these viruses to create biological agents for offensive use. Canada’s Public Health Agency along with the Royal Mounted Police assert that this “incident” is not a threat to public health. This lab is also being investigated following the dismissal of the lab’s head of the Vaccine Development and Antiviral Therapies’ Special Pathogens Program, one Xiangguo Qiu. Back on July 5, Qui, along with her husband/co-worker and a group of international students, all lost their security clearance.


    The Cat is Out of the Bag

    Henipah and Ebola are classified as bioterrorism agents by the US CDC, and they are easy to spread and cause high death rates. Both are Risk Group 4 pathogens, and they can be handled only in, “a lab with the highest level of biosafety control.” While health officials assert that all proper protocols were met, anonymous sources claims that this transfer shipment did not have a “material transfer agreement,” i.e. a contract spelling out the parties’ rights to intellectual property. Normally, such a document would safeguard Canada’s rights re the viruses if they were patented via the Budapest Treaty deposit, “an internationally recognized system for patenting intentions involving microorganisms.” Leah West, a national security law expert from the Norman Paterson School of International Affairs, notes, “If China was leveraging these scientists in Canada to gain access to a potentially valuable pathogen or to elements of a virus without having to license the patent…it makes sense with the idea of China trying to gain access to valuable IP without paying for it.” While China signed on to the Biological Weapons Convention back in 1984, most experts think the nations is leading the world in bioweapon production. “I would say this Canadian ‘contribution’ might likely be counterproductive. I think the Chinese activities . . . are highly suspicious, in terms of exploring [at least] those viruses as BW [biological warfare] agents,” according to Dany Shoham, biological and chemical warfare expert from Israel’s Bar-Ilan University. Mark Cohen is an expert on intellectual property issues in China, and he offers, “Frankly, if it’s already in China, cat’s out of the bag—-They’re probably culturing it already.”


    Seattle Doctor Finds Henipah in Chinese Data

    Our story picks up again on August 25, 2021 with The Epoch Times asserting that, “Samples From Early Wuhan COVID Patients Had Genetically Modified Henipah, One of Two Types of Viruses Sent From Canadian Lab.” A US scientist has found that samples from the original Wuhan patients with COVID-19 disclose the presence of Henipah virus that had been genetically modified. As noted, this virus was sent to China by Chinese-born personnel at the Canadian lab now in a controversy over both the firings and also over collaboration with researchers from the Chinese military. It is not clear at this time if the virus found in Wuhan samples is genetically related to the samples sent from Canada in late March 2019. Steven Quay, a Seattle doctor and scientist who used to teach at Stanford’s School of Medicine, found the evidence while looking at COVID-19 samples which had been put online by the Wuhan Institute of Virology soon after China told the WHO about the outbreak of SARS-CoV-2. The samples were from folks who were reported to have an “unidentified pneumonia disease” at the end of 2019.


    Genetically Modified Nipah Virus

    Noting that most scientists only wanted to look at the CoV-2 genome, Quay decided to see what else might be in the samples. He worked with several other experts to study gene sequences in the samples. “We started fishing inside for weird things,” Quay said. He says that his discoveries included material that looked like contamination from other experiments at the Wuhan lab, “as well as evidence of Henipah virus.” They discovered a genetically altered Nipah virus (a subtype of Henipah) that is more deadly than even Ebola. The Epoch Times sought out Joe Wang, PhD for further confirmation. Wang had formerly led a SARS vaccine program with a top pharma firm. (Wang is now NTD TV Canada’s president, and this is a “sister company” to The Epoch Times Canada.) Wang was able to duplicate Quay’s discovery re the Henipah virus, and he thinks that the gene manipulation was probably done for vaccine development reasons. Canadian government documents show that WIV’s planned use of the samples from Canada was “stock virus culturing,” aka live storage. Gene manipulation was not in the scope of the agreed and described usage.


    Chinese Military Researcher Worked at Canadian Lab

    Canada has seen controversy over the above-mentioned terminations of Qiu and her husband Keding Cheng. Opposition parties have been pressuring the government for more information about the case, while the later has refused to share information based on privacy and national security issues. In July 2019, the couple and some Chinese students were “escorted” from Canada’s only containment level 4 lab during a law enforcement investigation. In January 2021 the couple was officially fired. Authorities have said that the firings were resulting from an “administrative matter” along with “possible breaches of security protocols.” On June 21, Canadian House Speaker Anthony Rota criticized the Public Health Agency for not providing documents about the couple’s firing. Qiu visited the WIV several times while working for the Canadian lab; these were in her official capacity and aimed at helping to do training re level 4 safety. Media reports have suggested that NML scientists were working with the Chinese military and that they had hosted a Chinese military researcher who worked at the Canadian lab, “for a period of time.”


    “Good to Know…You Trust this Group”

    David Safronetz, who is the chief of special pathogens at Canada’s health agency, sent an email to NML administrators in September 2018 informing them of the WIV request for viruses. His email stated, “I trust the lab.” In reply, NML’s chief asks what type of work would be done at Wuhan and why the later would not obtain samples from, “other, more local labs.” He also said that its, “good to know that you trust this group.” Replying back, Safronetz fails to say what the use of the samples will be. But he points out that samples will only be sent when the paperwork and certification are complete. He also notes that WIV is asking NML for the samples, “due to collaboration” with Qiu. He offers, “Historically, it’s also been easier to obtain material from us as opposed to US labs. I don’t think other, closer labs have the ability to ship these materials.” Government MPs are asking NML why the shipments were allowed and whether they had knowledge that China does gain-of-function work at Wuhan. NML’s acting scientific director Guillaume Poliquin informed MPs on March 22 that the lab had been assured that no gain-of-function research would be done with the transferred viruses.


    Questions Surround Canadian Shipment of Deadly Viruses to China
    The same Winnipeg lab that sent Ebola and Henipah viruses to Beijing recently removed a number of researchers for an administrative issue.
    www.the-scientist.com

    I posted a story resently of a brave doctors prescribing ivermectin to state inmates, now they are coming after the doctor. Just as the FLCCC has warned!!!


    Arkansas doctor under investigation for prescribing anti-parasitic drug thousands of times for Covid-19 despite FDA warning


    Arkansas doctor under investigation for prescribing anti-parasitic drug thousands of times for Covid-19 despite FDA warning
    The Arkansas Medical Board is investigating after a doctor said he prescribed an anti-parasitic drug "thousands" of times for treatment of Covid-19, including…
    amp.cnn.com


    CNN)The Arkansas Medical Board is investigating after a doctor said he prescribed an anti-parasitic drug "thousands" of times for treatment of Covid-19, including to inmates in an Arkansas jail.


    The FDA has been warning against the use of ivermectin for treatment of Covid-19 since March. The drug is used to treat parasitic infections, primarily in livestock, and the CDC recently cautioned about an increase in reports to poison centers of severe illness caused by the drug.


    Justice of the Peace Eva Madison raised the issue during a county budget hearing in Fayetteville on Tuesday, saying a county employee had told her the jail's medical provider was prescribing ivermectin to treat and prevent Covid-19.

    The county employee -- who doesn't work for the sheriff's department -- was directed to the jail to receive a Covid-19 test, Madison told CNN. During the visit he was prescribed ivermectin, which the Arkansas Department of Health also advises not to use to treat or prevent Covid-19.


    "He is very afraid of retribution from the county and so he asked me to raise this issue on his behalf," Madison said.


    "Much to my surprise, he (the sheriff) defended the use. He defended the practice," Madison said. The sheriff offered to put Madison in touch with the medical provider. Screen shots of the text exchange with the sheriff provided by Madison confirm her account.


    Dr. Robert Karas provides medical services to the Washington County jail. He has been the contracted provider since 2015, according to Madison.

    Madison said Karas defended his use of the drug during a phone conservation and again in a subsequent television interview after the practice came to light. Karas told television station KFSM that he began last October with prescribing the drug and has subsequently given it to family members and "thousands" of others. The doctor also recorded the station's interview with his own camera and posted it online.


    "Do you want us to try and fight like we're at the beaches of Normandy? Or do you want me to tell what a lot of people do and say -- oh, go home and ride it out and go to the ER when your lips turn blue," Karas said.


    Karas said that he started to use ivermectin in the jail population starting in November on "high-risk patients over 40." The doctor defended his practice ,saying no deaths have been reported due to Covid-19 out of the 531 cases in the jail.


    CNN called the Washington County Sheriff's Office to confirm the number of Covid-19 patients treated at the jail and was referred back to Karas, since he is contracted to provide medical services. Calls to the doctor's office have not been returned.

    The Arkansas Medical Board has opened an investigation into the matter, Meg Mirivel, a spokesperson for the Arkansas Department of Health, told CNN. Due to the ongoing investigation the department was not able to comment further.


    The sheriff's department declined to comment further or provide additional information about inmate care.


    The Sheriff's office defended the practices to the local paper, saying all treatment is "voluntary."


    "They are able to refuse any medication they're offered. Even with the vaccine, it's all voluntary," Chief Deputy Jay Cantrell told the Northwest Arkansas Democrat-Gazette.

    I believe it's the county and the sheriff's constitutional duty to provide the detainees adequate and appropriate medical care." Madison told CNN.


    "No one -- including incarcerated individuals -- should be subject to medical experimentation," Holly Dickson, executive director of the ACLU of Arkansas, said in a statement, adding that the sheriff "has a responsibility to provide food, shelter and safe, appropriate care to incarcerated people."


    In a CDC health advisory issued Thursday, the agency said the use of ivermectin can result in "gastrointestinal symptoms such as nausea, vomiting, and diarrhea. Overdoses are associated with hypotension and neurologic effects such as decreased consciousness, confusion, hallucinations, seizures, coma, and death."

    Quote from THHuxleynew

    Not evidenced. And it is a question I'm interested in and would like to find evidence on.


    It is really not clear whether vaccines or infection protect you better in general. It depends who you are, how bad was the infection, how recently you were vaccinated, which vaccine. It also depends on whether the infection was with an old variant or the current (delta) variant.


    What is clear is that vaccination adds protection to whatever you would have just from infection, and that infection alone - especially mild infection - is not great protection.

    This is now 2 studies that show natural immunity is better than vaccination and the first one I posted tells you why!



    Having SARS-CoV-2 once confers much greater immunity than a vaccine—but no infection parties, please


    Having SARS-CoV-2 once confers much greater immunity than a vaccine—but no infection parties, please
    Israelis who had an infection were more protected against the Delta coronavirus variant than those who had an already highly effective COVID-19 vaccine
    www.sciencemag.org


    The natural immune protection that develops after a SARS-CoV-2 infection offers considerably more of a shield against the Delta variant of the pandemic coronavirus than two doses of the Pfizer-BioNTech vaccine, according to a large Israeli study that some scientists wish came with a “Don’t try this at home” label. The newly released data show people who once had a SARS-CoV-2 infection were much less likely than vaccinated people to get Delta, develop symptoms from it, or become hospitalized with serious COVID-19.


    The study demonstrates the power of the human immune system, but infectious disease experts emphasized that this vaccine and others for COVID-19 nonetheless remain highly protective against severe disease and death. And they caution that intentional infection among unvaccinated people would be extremely risky. “What we don’t want people to say is: ‘All right, I should go out and get infected, I should have an infection party.’” says Michel Nussenzweig, an immunologist at Rockefeller University who researches the immune response to SARS-CoV-2 and was not involved in the study. “Because somebody could die.”


    The researchers also found that people who had SARS-CoV-2 previously and then received one dose of the Pfizer-BioNTech messenger RNA (mRNA) vaccine were more highly protected against reinfection than those who once had the virus and were still unvaccinated.

    The study, conducted in one of the most highly COVID-19–vaccinated countries in the world, examined medical records of tens of thousands of Israelis, charting their infections, symptoms, and hospitalizations between 1 June and 14 August, when the Delta variant predominated in Israel. It’s the largest real-world observational study so far to compare natural and vaccine-induced immunity to SARS-CoV-2, according to its leaders.


    The research impresses Nussenzweig and other scientists who have reviewed a preprint of the results, posted yesterday on medRxiv. “It’s a textbook example of how natural immunity is really better than vaccination,” says Charlotte Thålin, a physician and immunology researcher at Danderyd Hospital and the Karolinska Institute who studies the immune responses to SARS-CoV-2 . “To my knowledge, it’s the first time [this] has really been shown in the context of COVID-19.”


    Still, Thålin and other researchers stress that deliberate infection among unvaccinated people would put them at significant risk of severe disease and death, or the lingering, significant symptoms of what has been dubbed Long Covid. The study shows the benefits of natural immunity, but “doesn’t take into account what this virus does to the body to get to that point,” says Marion Pepper, an immunologist at the University of Washington, Seattle. COVID-19 has already killed more than 4 million people worldwide and there are concerns that Delta and other SARS-CoV-2 variants are deadlier than the original virus.


    The new analysis relies on the database of Maccabi Healthcare Services, which enrolls about 2.5 million Israelis. The study, led by Tal Patalon and Sivan Gazit at KSM, the system’s research and innovation arm, found in two analyses that people who were vaccinated in January and February were, in June, July, and the first half of August, six to 13 times more likely to get infected than unvaccinated people who were previously infected with the coronavirus. In one analysis, comparing more than 32,000 people in the health system, the risk of developing symptomatic COVID-19 was 27 times higher among the vaccinated, and the risk of hospitalization eight times higher.


    “The differences are huge,” says Thålin, although she cautions that the numbers for infections and other events analyzed for the comparisons were “small.” For instance, the higher hospitalization rate in the 32,000-person analysis was based on just eight hospitalizations in a vaccinated group and one in a previously infected group. And the 13-fold increased risk of infection in the same analysis was based on just 238 infections in the vaccinated population, less than 1.5% of the more than 16,000 people, versus 19 reinfections among a similar number of people who once had SARS-CoV-2.


    No one in the study who got a new SARS-CoV-2 infection died—which prevented a comparison of death rates but is a clear sign that vaccines still offer a formidable shield against serious disease, even if not as good as natural immunity. Moreover, natural immunity is far from perfect. Although reinfections with SARS-CoV-2 are rare, and often asymptomatic or mild, they can be severe.


    In another analysis, the researchers compared more than 14,000 people who had a confirmed SARS-CoV-2 infection and were still unvaccinated with an equivalent number of previously infected people who subsequently received one dose of the Pfizer-BioNTech vaccine. (In Israel, it’s recommended that people who have been previously infected get just one dose.) The team found that the unvaccinated group was twice as likely to be reinfected as the singly vaccinated.


    “We continue to underestimate the importance of natural infection immunity … especially when [infection] is recent,” says Eric Topol, a physician-scientist at Scripps Research. “And when you bolster that with one dose of vaccine, you take it to levels you can’t possibly match with any vaccine in the world right now.”


    Nussenzweig says the results in previously infected, vaccinated people confirm laboratory findings from a series of papers in Nature and Immunity by his group, his Rockefeller University colleague Paul Bieniasz and others—and from a preprint posted this month by Bieniasz and his team. They show, Nussenzweig says, that the immune systems of people who develop natural immunity to SARS-CoV-2 and then get vaccinated produce exceptionally broad and potent antibodies against the coronavirus. The preprint, for example, reported that people who were previously infected and then vaccinated with an mRNA vaccine had antibodies in their blood that neutralized the infectivity of another virus, harmless to humans, that was engineered to express a version of the coronavirus spike protein that contains 20 concerning mutations. Sera from vaccinated and naturally infected people could not do so.


    As for the Israel medical records study, Topol and others point out several limitations, such as the inherent weakness of a retrospective analysis compared with a prospective study that regularly tests all participants as it tracks new infections, symptomatic infections, hospitalizations, and deaths going forward in time. “It will be important to see these findings replicated or refuted,” says Natalie Dean, a biostatistician at Emory University.


    She adds: “The biggest limitation in the study is that testing [for SARS-CoV-2 infection] is still a voluntary thing—it’s not part of the study design.” That means, she says, that comparisons could be confounded if, for example, previously infected people who developed mild symptoms were less likely to get tested than vaccinated people, perhaps because they think they are immune.


    Nussenzweig’s group has published data showing people who recover from a SARS-CoV-2 infection continue to develop increasing numbers and types of coronavirus-targeting antibodies for up to 1 year. By contrast, he says, twice-vaccinated people stop seeing increases “in the potency or breadth of the overall memory antibody compartment” a few months after their second dose.


    For many infectious diseases, naturally acquired immunity is known to be more powerful than vaccine-induced immunity and it often lasts a lifetime. Other coronaviruses that cause the serious human diseases severe acute respiratory syndrome and Middle East respiratory syndrome trigger robust and persistent immune responses. At the same time, several other human coronaviruses, which usually cause little more than colds, are known to reinfect people regularly

    Quote from Fm1

    Sino-Canadian Skullduggery? Canada Sent Dangerous Henipah Virus to China In 2019, and Early Wuhan Samples Show Modified Version of This Pathogen

    China is by far the biggest investor in Canada. The whole China politics mafia has bought properties in Vancouver Dozen of billions $$$.

    Quote from Fm1

    "No one -- including incarcerated individuals -- should be subject to medical experimentation," Holly Dickson, executive director of the ACLU of Arkansas, said in a statement, adding that the sheriff "has a responsibility to provide food, shelter and safe, appropriate care to incarcerated people."

    This is the true America (USA)- A Sheriff that looks after his prisoners by allowing/supporting Ivermectin treatment with no fatalities so far!. May be "free" Americans are the real prisoners today...

    Quote from Fm1

    The researchers also found that people who had SARS-CoV-2 previously and then received one dose of the Pfizer-BioNTech messenger RNA (mRNA) vaccine were more highly protected against reinfection than those who once had the virus and were still unvaccinated.

    The absolute difference is small and some Ig*-cells also decrease after vaccination. More research is needed!

    They should add a (third) vaccine only branch.


    You can also compare with https://doi.org/10.1101/2021.04.19.21255739


    Or earlier: https://doi.org/10.1038/s41467-021-24979-9


    Or here a bit less demanding: https://www.nature.com/articles/s41577-021-00550-x


    Gives a good overview for many questions including real live protection:

    A large cohort study compared the incidence of SARS-CoV-2 infection in health-care workers who were either seropositive (indicating recent previous infection) or seronegative for SARS-CoV-2 at enrolment53. This study estimated that seropositivity at enrolment reduced the incidence of detected reinfection by almost 89% over a median follow-up of 139 days. A retrospective study of more than 43,000 participants in a national database in Qatar has estimated a reduction of infection of 95% in seropositive individuals over a median of 114 days from a seropositive test (preprint data, not yet peer reviewed)


    Please remember that healthcare workers are not the real situation. In an Argentina study nearly 50% contained the virus within 6 months!

    As all papers say: Do avoid high transmission situations.




    CoV-19 is still a disease of the old:

    Covid-⁠19 Schweiz | Coronavirus | Dashboard
    Covid-⁠19 Pandemie Schweiz und Liechtenstein: Fallzahlen, Virusvarianten, Hospitalisationen, Re-⁠Wert, Spitalkapazitäten, internationale Lage, Zahlen zu Tests,…
    www.covid19.admin.ch


    Age class 50..69 has < 20x less risk that age class > 80.


    Here I fully agree that these folks (age >=80) should take a gen therapy!


    The age class 70..80 usually has 2-3x the risk of 50..69. One week here was an exception.


    Deaths among 0..50 still are extremely rare. Once within 2 weeks! Among 8.7 mio. people! Last half year.

    Jerusalem’s Herzog Medical Center Reports on Dramatic Reduction of Age 60+ Infection Rates Associated with COVID-19 Booster Vaccine Program


    Jerusalem’s Herzog Medical Center Reports on Dramatic Reduction of Age 60+ Infection Rates Associated with COVID-19 Booster Vaccine Program
    TrialSite recently covered reports of disturbing COVID-19 Delta-variant-driven breakthrough infections in Israel, centering on a television
    trialsitenews.com



    TrialSite recently covered reports of disturbing COVID-19 Delta-variant-driven breakthrough infections in Israel, centering on a television interview of the head of Herzog Medical Center in that nation. Recently, the leadership of Herzog Medical Center, an internationally known academic medical center focusing on aging and behavioral health, reported important updates on the unfolding situation as the country experiences a surge in cases. Notably, the hospital’s President, Yehezkel Caine, M.D., M.Sc., shared with TrialSite national Israeli data as of August 25 revealing that those unvaccinated aged 60 and above have an 11 fold increase of COVID-19 infection as compared to individuals that received the recent Pfizer-BioNTech booster dose.


    The Delta Surge in Israel

    By August 25, the daily new case 7-day average grew to 7,947 in Israel based on data from the COVID-19 Data Repository, Center for Systems Science and Engineering (CSSE), Johns Hopkins University. Disturbingly, the average daily number of new deaths climbed to 26 in one of the most vaccinated nations. However, as discussed below, early signs indicate a booster program here already produces dramatic results, especially for the high-risk aged 60 and above cohort.


    Combatting the Pandemic

    According to hospital officials, the largest continuously operating COVID-19 treatment center in the country, Herzog Medical Center, serves the nation as a SARS-CoV-2 referral center. Academic medical centers are strategically positioned in this part of Israel to care for the highest risk group in this pandemic—the elderly.


    Thus, Herzog Medical Center has been front and center in the war against COVID-19, with intense media coverage, numerous newspaper and television interviews with many interpretations of the Israeli hospital leaderships’ position on critical matters such as vaccination. The team at Herzog Medical Center recently shared with TrialSite the importance they place on the vaccine-centric strategy to ultimately overcome the virus.


    Waning Vaccine Effectiveness

    Herzog Medical Center’s President, Yehezkel Caine, M.D., M.Sc., contacted TrialSite’s founder, Daniel O’Connor, to clarify what they believe was an incorrect perception created from a recent Israeli television interview. That was the Channel 13 interview of Dr. Koby Haviv, Director of the Jerusalem-based hospital, who discussed the high number of breakthrough infections and hospitalizations associated with vaccinated individuals. With the Delta outbreak, all data points to waning vaccine effectiveness but not the Herzog Medical Center team’s commitment to the vaccine-centric strategy—which remains steadfast.


    Dr. Caine communicated to TrialSite’s founder via email, emphasizing that the waning effectiveness of the vaccine was expected given the confluence of unfolding factors such as the highly transmissible and virally loaded Delta variant. Dr. Caine reports that the data collected at this important health care hub points to a decrease in the effectiveness of the Pfizer-BioNTech vaccine and possibly the Moderna product. He emphasized that at least based on the data observed at the hospital, the mRNA-based vaccine’s effectiveness “…decreased from 95% initially two weeks post second dose…down to around 40% prevention of infection at 5 to 6 months.”




    Importantly, Dr. Caine clarified for the TrialSite reader the powerful preventative features of the vaccine. The Israeli academic medical center specializing in elderly care supports vaccination as a fundamental move to fight off the novel coronavirus.


    Caine shared that the Pfizer-BioNTech vaccine was up to 99% effective in preventing severe disease upon administration of the second dose at 5 to 6 months. Even with the Delta variant in circulation, the vaccine remains 80% effective at preventing severe disease, indicating highly protective strengths during the pandemic even a half year after vaccine administration.


    First Movers

    Israel represents a critically important place to understand how the COVID-19 vaccines work in the bid to protect society from this ongoing pandemic. Why? Because the nation moved faster than most others to accelerate COVID-19 vaccination programs. This means that, worldwide, the Israeli population was the first to benefit from the vaccines. Of course, they are among the first to experience the waning effectiveness, which is to be expected of most vaccines.


    Dr. Caine shared that segmenting vaccine effectiveness by important cohorts such as age points to key discussion points. Presently, 92% of the Israeli population aged 65 and above have been vaccinated with two (2) doses, and most of that cohort received the last dose approximately 7 to 8 months ago. Thus the hospital staff was among the first to experience the rise in breakthrough infections in the elderly population.


    Israel Vaccination Data

    Herzog Medical Center provided the most recent vaccination numbers in Israel by age cohort:


    Age Group % Dose First % Dose Second % Dose Third

    12-15 44.4 30.2 0

    16-19 80.2 69.3 0.2

    20-29 80.1 72.8 1.2

    30-39 84.4 78.3 8.4

    40-49 87.4 81.7 24.1

    50-59 90.6 85.3 44.7

    60-69 91.5 87.7 63.7

    70-79 96.1 93.5 78.9

    80-89 94.7 92 74.9

    90+ 94.2 90.6 69.7

    Hospitalization Data

    Herzog Medical Center has cared for about 200 patients during this latest Delta variant-driven pandemic surge, with about 40 in the hospital as of today, which is down from 80 a couple of weeks ago. Of the total, Dr. Caine reports 26% were not vaccinated, representing a higher number than their proportion in the population which stands at 8%.


    Generally, during this latest wave, vaccinated hospitalized patients are experiencing more mild forms of the illness, but some are more severe—about 35% in total. However, their numbers, as represented by a percentage of the total population, are considerably less.


    Herzog Medical Center Booster Tracking—Positive Signals

    TrialSite received near real-time updates from Dr. Caine and team, who informed us that 66% of Israelis aged 60 and above recently received their third booster dose, and the numbers look quite promising. According to Caine, the “numbers have dropped drastically, and even those infected are following a much milder course.” The effect appears to be rippling throughout Jerusalem as Cain shared, “As of today, only one patient has been admitted to our hospital with moderate to severe disease following the third vaccine.”


    Real-Time National Data Revealing

    That the booster has impacted Herzog Medical Center’s patient catchment area positively seems apparent based on the drastic drop in new patient hospitalizations. But what’s going on nationally? Dr. Yehezkel Caine shared that the following data as of August 25th evidencing the major impact of the booster program:


    Age Group Non-Vaccinated Vaccinated (2 doses)

    Infection Rate Under 60 4.1 per 100,000 1.4 per 100,000

    Infection Rate Age 60 + 244.6 per 100,000 21.1 per 100,000

    The data indicates a stunning 11 fold decrease in infections in the elderly due to the booster program ongoing in Israel. TrialSite acknowledges this notable data point. Herzog Medical Center shared that approximately one million adults and 2.5 million children still are not vaccinated in Israel. Herzog Medical Center shared that children by no means represent a majority of cases, “but they are undoubtedly amongst the carriers.”


    Debate: Children

    TrialSite concurs with Dr. Caine and the Herzog Medical Center team that children are, in fact, carriers. However, the rush to vaccinate children must be tempered by a few considerations, including 1) risks for infection, 2) risks for morbidity and mortality, 3) safety risk associated with the vaccine product, and 4) with the Delta variant, the vaccinated are frequently vectors, thus diminishing the argument that children should be vaccinated to mitigate transmission.


    With the Channel 13 interview, many here at Herzog Medical Center felt some twisted it with an anti-vaccination point of view. The opposite is true. They argue here that the vaccination program has saved many lives and, at least to date, indicates a dramatic decrease in risks of infection for those aged 60 and above.


    Herzog Heroes

    TrialSite commends the heroes at Herzog Medical Center, a major nexus of COVID-19 care in Israel. Dr. Caine is at the forefront of combating the pandemic, who shared that thanks to the Israeli booster program, prospects for a slowdown in cases feel imminent. He declared: “So, I think that we are in for a busy summer in the hospital but hopefully, with the third dose for the over 60s (and now also for the 30s and above) we should start seeing an effect within two weeks. As mentioned, we are already seeing a slight drop in the over 60s.”


    TrialSite Point of View

    The data points out of Israel are significant, indicating a powerful benefit of vaccination. TrialSite raises concerns about more intermediate to long-term ramifications of depending solely on vaccine-centric strategies, not factoring in early treatment and other public health measures. For example, what happens if another variant emerges in six months that is even stronger and more infectious than Delta? The costs and potential health implications of vaccines must be better understood. These products remain novel, and little to nothing is known about longer-term impacts. Objective, unbiased, patient-centric research and associated data monitoring remain a vital function driven by health care institutions such as Herzog Medical Center.


    Herzog Medical Center

    Based in Jerusalem, Herzog Medical Center traditionally specialized in nursing care for the elderly, and its origins date back to 1894 as a psychiatric hospital. Today, the hospital continues its important work in psychiatry. Still, with almost 400 beds (excluding COVID beds), it has become one of the largest centers for respiratory care, with over 200 patients of all ages (from infants through the very elderly) dependent on ventilators, the largest rehabilitation center in the Jerusalem area, and a place for acute geriatric care.


    Also an academic medical center, Herzog maintains a teaching hospital providing student and residency training in Geriatrics and Psychiatry, Psychology, and Social work in affiliation with Hebrew University-Hadassah Medical School.


    Call to Action: Herzog Medical Center also suggested TrialSite call attention to a recently published study titled “Safety of the BNT162b2 RNA Covid-19 Vaccine in a Nationwide Setting.” It originated from Israel’s largest HMO – Clalit – and looked at a large, population-based cohort of approximately 2 million members of the HMO to study the vaccine’s safety profile. The study was peer-reviewed, published in the New England Journal of Medicine, and can be accessed here.

    https://www.nejm.org/doi/full/10.1056/NEJMoa2110475

    I heard it best from a TV talking head: "this pandemic has warped our economy, and warped our society" This article is a good example of how it has warped us as a society.


    We have been reminded many times that doctors are free to use IVM "off label" for COVID. Yet this doctor did just that, and as a result was turned in by an anonymous whistleblower, is being chased by reporters as if he were a criminal, the ACLU has accused him of doing "medical experimentation" on prisoners, and now he is being investigated by the states Medical Board.


    His life is forever changed for simply trying to do what he thought best for his patients, and was legal for him to do. What a sick country we have become.

    Quote from Fm1

    Israeli data as of August 25 revealing that those unvaccinated aged 60 and above have an 11 fold increase of COVID-19 infection as compared to individuals that received the recent Pfizer-BioNTech booster dose.

    This is not very good news: You have three vaccinations and only an efficiency of about 90% after 4 weeks. This from live data! We had 99% after 2 shots in all regions. But everything depends on the pandemic situation.


    So this already points to an ADE increase by a factor 10!

    Quote from Fm1

    He emphasized that at least based on the data observed at the hospital, the mRNA-based vaccine’s effectiveness “…decreased from 95% initially two weeks post second dose…down to around 40% prevention of infection at 5 to 6 months.”

    He has a bad memory 95% was for > 3 months...So basically he is a FUD'er...

    The same impression we get from the rest he says - "still 80% efficiency from Pfizer". So he is shameless liar. Why do they go for the booster ? Because it dropped to 15% recently for the early vaccinated...

    The UK Dept. of Health published some data about the Delta variant. I looked at it yesterday and got terribly confused. I think I now understand, and it isn't that complicated, but it sure had me mixed up! I thought I would go over it here. It is in this Technical Briefing:


    https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1009243/Technical_Briefing_20.pdf


    Table 5 on p. 18 and 19 seems to show that vaccinating old people makes them sick! Here is row 1, "Delta cases." The red box in this image shows that with patients over age 50, the fully vaccinated group ("Received 2 doses") had 21,472 cases, and the Unvaccinated group had 3,440 cases. So, 64% of cases were fully vaccinated, 10% unvaccinated, and 26% are in other categories.



    To understand this, you have to look at other data. A BBC article shows what you need to know. It shows that most people over age 50 were vaccinated before April 2021, before the rest of the population. They were prioritized. See the graph "How vaccination rates compare by age:"


    Covid vaccine: How many people in the UK have been vaccinated so far?
    The progress made in vaccinating the country's adult population, as more than 47 million people have received at least one dose.
    www.bbc.com


    It also shows that 87% to 95% of people over 50 are now vaccinated, as of August 19, 2021. See the graph "Percentage of those over aged 50 and over vaccinated . . ."


    The data in the Technical Briefing runs from February to August, as shown in the table heading. During most of this time, between 80% and 90% of people over age 50 were fully vaccinated. So, even though Delta breakthrough cases occur less often than unvaccinated cases, in absolute numbers there were more breakthrough cases because there were so many more vaccinated old people. There are not many unvaccinated old people left for the virus to target.


    To put it simply --


    There are more infected vaccinated old people because they are a large majority of all old people. Even though breakthrough cases are rare, when 90% of the group can only have a breakthrough case, there will be more of them than unvaccinated cases. As I said, if 100% of over-50 people were vaccinated, there would only be breakthrough cases.


    The older UK population resembles the Provincetown group, with ~90% vaccinated:


    ‘It’s Nowhere Near Over’: A Beach Town’s Gust of Freedom, Then a U-turn
    Provincetown, Mass., the quirky community at the tip of Cape Cod, thought it was safe to return to prepandemic partying. It wasn’t.
    www.nytimes.com

    Coronavirus Disease 2019 (COVID-19)
    CDC provides credible COVID-19 health information to the U.S.
    www.cdc.gov


    If I have done my arithmetic right -- which is never assured! -- the data shows:


    On July 4, ~60,000 people gathered in the town. It was crowded and there was no social distancing.

    A COVID outbreak followed, with 965 cases reported.

    75% of the patients were fully vaccinated breakthrough cases. That is 724 vaccinated and 240 unvaccinated people.

    There were no deaths, and only 7 patients hospitalized.


    There were ~54,000 vaccinated people and ~6,000 unvaccinated. 724 (1.3%) of the vaccinated people were infected, and 240 (4.0%) of unvaccinated people were infected. The vaccination reduced the chance of infection by around 68%. Similar numbers have been observed elsewhere, which is why the CDC and others estimate a ~65% reduction in infection, compared to a ~90% reduction with the Alpha variant.

    Quote from Fm1

    I'm not sure I agree, 1- reinfection seems to be much more rare than vaccine breakthrough and natural immunity provides a certain antibody S2H97 that vaccination does not. I posted the study a few weeks back but as usual it was a treatment and you probably didn't care as it didn't involve vaccination

    FM1 - you have not found evidence of me ignoring what you post - just I don't over-interpret it.


    In this case you say I ignore evidence that natural infection is broader than vaccine immune response. I've repeatedly agreed that is so (hence you would expect extra antibodies). The issue is however whether it works better, and that is a matter of both which antibodies and what level they are in the blood and also how many of the relevant memory cells exist etc etc.


    It is really complex to decide from all that what the actual protection will be - which is why I tend to ignore these lab results. They do not tell you anything practical. You may consider yourself cleverer than everyone else and able to interpret them - I will need some convincing of that.


    What I would like, and have not found, is a comparison between efficacy against serious disease of those vaccinated and those previously infected not vaccinated. That will also be not accurate, because it depends on which variant infected, and how long between infection or vaccination and re-infection. But still it should be possible to get some results.


    I have not seen them yet. Maybe somone else has.


    THH


    PS - not sure why you think I don't care about treatments - I've posted quite a bit about them. I am more interested in the clinical stuff where it has gone to phase 1 at least and has some chance of being rolled out within 6 months rather than the lab this might be a good idea stuff. Antibody treatments are one of the key things, so good antibodies are obviously important, but there is a long way to go between identifying them and finding out how safe and effective they are in humans.


    Generally, I'd say it is more difficult to make mAbs safe than vaccines safe, since vaccines use everyone's own immune system which has been tuned only to make antibodies that are safe.


    The safety and side effects of monoclonal antibodies - PubMed
    Monoclonal antibodies (mAbs) are now established as targeted therapies for malignancies, transplant rejection, autoimmune and infectious diseases, as well as a…
    pubmed.ncbi.nlm.nih.gov

    That ONS survey - England infection rate is now back at 1:70 (between 1:70 and 1:75).


    That is a bit depressing since the sequence is now:


    1:70

    1:80

    1:75

    1:75


    So basically infections are flat but bound to increase when schools go back.


    The depressing thing is that high infection rates can only be changed by long severe lockdown (not going to happen) or enough natural immunity that when added to vaccine immunity we get R << 1. I'm not sure with delta that is possible.


    If you reckon that maybe 50% of the population are still vulnerable to spreading COVID, then a rate of 1 in 70 means that we 35 weeks for everyone to catch COVID. A rate much higher than 1:40 is going to be strectching health serviced, even given high UK vaccination.


    Last wave we were at 3700 hospitalisations (England) vs around 780 now. Last wave was very uncomfortable for health service. It will be worse this winter because without lockdown we will see much higher Flu rates as well.


    I guess you might reckon double current rate is sustainable, more will be really tough. At double current we have 17 weeks to everyone having caught it who is going to do so.


    It looks a bit long to me - so I expect we will agree child vaccinations for > 12 year olds, which would help a bit?


    The whole COVID/vaccine situation is trying to get through to everyone having immunity without too many dying in the process. This winter looks nasty, even if we have no variants.


    We can hope for better treatments (mAbs) in time for that? And treatments that can be self-administered at home.


    Coping with COVID - in the real world when not dealing with internet anti-vaxers - is not about a war between treatments and vaccines. We are going to need both to get out of this. the current vaccines are a quick fix allowing democracies to get out of lockdowns that would otherwise be forced.


    Places like UP in India are not quite the same:

    1/5 the overall morbidity juts based on population age

    autocratic government that can massage official figures

    most of province is rural peasants no health service people juts die of undiagnosed fever.


    So very high peak COVID infection and death rates can be sustained.

    Quote from Nar

    See https://www.nhs.uk/conditions/…ations/child-flu-vaccine/ ....its a nasal spray so secure from Mr. Gates' dastardly schemes.

    Nasal spray types for children are also used in the US. I wish they worked for adults but alas the doctors say we must be inoculated.



    There is a great deal of confusion about the subcutaneous implants that people imagine Mr. Gates is putting in us. That is because people who believe such nonsense are easily confused. Just to clarify:


    There are implantable RFID devices, used with pets. Look up "microchips for pets."


    They have a range of a few meters.


    They are "enclosed in a glass cylinder, about 11-14 mm long and 2-2.3 mm thick, the chip is about the size of a grain of rice." So, you cannot fit one in a hypodermic needle. You would probably notice if someone implanted one in your arm.


    They are not GPS devices or radios, so they do not work over long distances, and you cannot track a pet with them. If a vet or dog catcher finds your dog, he can use a RIFID reader to identify the animal from a few meters away. You cannot follow the animal on a map, the way the telephone company can follow your cell phone. (Can follow, does follow, and sells your data to anyone whose money is green!)


    In Sweden, people use implanted RFID devices in their hands to pay for things, like a credit card. I kid you not:


    In Sweden, cash is almost extinct and people implant microchips in their hands to pay for things
    financialpost.com


    You can also buy a cell phone collar for your dog, that will allow you to follow the animal on a map. It is much bigger than a grain of rice. It resembles the ankle bracelets that people on probation have to wear.



    Many paranoid, ignorant fools think that Bill Gates is implanting tracking devices. My guess is that most of these people carry cell phones, which is ironic. A cell phone is a tracking device, and the telephone companies all track them. As I said, they sell the tracking data to advertisers, or to just about anyone for any purpose, according to various news reports. Perhaps the laws have been updated but a few years ago they could sell to anyone. The New York Times purchased a database and tracked several people, including President Trump.

    Quote from THHuxleynew

    The depressing thing is that high infection rates can only be changed by long severe lockdown (not going to happen) or enough natural immunity that when added to vaccine immunity we get R << 1. I'm not sure with delta that is possible.

    I think a booster shot or a reformulated mRNA vaccine might lower the infection rate. I hope so.

    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study


    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study
    Objective To assess the association between covid-19 vaccines and risk of thrombocytopenia and thromboembolic events in England among adults. Design…
    www.bmj.com


    Abstract

    Objective To assess the association between covid-19 vaccines and risk of thrombocytopenia and thromboembolic events in England among adults.


    Design Self-controlled case series study using national data on covid-19 vaccination and hospital admissions.


    Setting Patient level data were obtained for approximately 30 million people vaccinated in England between 1 December 2020 and 24 April 2021. Electronic health records were linked with death data from the Office for National Statistics, SARS-CoV-2 positive test data, and hospital admission data from the United Kingdom’s health service (NHS).


    Participants 29 121 633 people were vaccinated with first doses (19 608 008 with Oxford-AstraZeneca (ChAdOx1 nCoV-19) and 9 513 625 with Pfizer-BioNTech (BNT162b2 mRNA)) and 1 758 095 people had a positive SARS-CoV-2 test. People aged ≥16 years who had first doses of the ChAdOx1 nCoV-19 or BNT162b2 mRNA vaccines and any outcome of interest were included in the study.


    Main outcome measures The primary outcomes were hospital admission or death associated with thrombocytopenia, venous thromboembolism, and arterial thromboembolism within 28 days of three exposures: first dose of the ChAdOx1 nCoV-19 vaccine; first dose of the BNT162b2 mRNA vaccine; and a SARS-CoV-2 positive test. Secondary outcomes were subsets of the primary outcomes: cerebral venous sinus thrombosis (CVST), ischaemic stroke, myocardial infarction, and other rare arterial thrombotic events.


    Results The study found increased risk of thrombocytopenia after ChAdOx1 nCoV-19 vaccination (incidence rate ratio 1.33, 95% confidence interval 1.19 to 1.47 at 8-14 days) and after a positive SARS-CoV-2 test (5.27, 4.34 to 6.40 at 8-14 days); increased risk of venous thromboembolism after ChAdOx1 nCoV-19 vaccination (1.10, 1.02 to 1.18 at 8-14 days) and after SARS-CoV-2 infection (13.86, 12.76 to 15.05 at 8-14 days); and increased risk of arterial thromboembolism after BNT162b2 mRNA vaccination (1.06, 1.01 to 1.10 at 15-21 days) and after SARS-CoV-2 infection (2.02, 1.82 to 2.24 at 15-21 days). Secondary analyses found increased risk of CVST after ChAdOx1 nCoV-19 vaccination (4.01, 2.08 to 7.71 at 8-14 days), after BNT162b2 mRNA vaccination (3.58, 1.39 to 9.27 at 15-21 days), and after a positive SARS-CoV-2 test; increased risk of ischaemic stroke after BNT162b2 mRNA vaccination (1.12, 1.04 to 1.20 at 15-21 days) and after a positive SARS-CoV-2 test; and increased risk of other rare arterial thrombotic events after ChAdOx1 nCoV-19 vaccination (1.21, 1.02 to 1.43 at 8-14 days) and after a positive SARS-CoV-2 test.


    Conclusion Increased risks of haematological and vascular events that led to hospital admission or death were observed for short time intervals after first doses of the ChAdOx1 nCoV-19 and BNT162b2 mRNA vaccines. The risks of most of these events were substantially higher and more prolonged after SARS-CoV-2 infection than after vaccination in the same population.

    Quote from Shane D.

    We have been reminded many times that doctors are free to use IVM "off label" for COVID. Yet this doctor did just that, and as a result was turned in by an anonymous whistleblower, is being chased by reporters as if he were a criminal, the ACLU has accused him of doing "medical experimentation" on prisoners, and now he is being investigated by the states Medical Board.


    His life is forever changed for simply trying to do what he thought best for his patients, and was legal for him to do.

    I suggest you wait to see the results of the investigation before passing judgement. Medical Boards seldom investigate doctors. They usually have a good reason for doing this. It is possible they are scapegoating him, but it is also possible he has committed malpractice and should be censured. You cannot judge because you do not have the testimony or technical details. I could not judge even if I had them, because I do not know enough about medicine.


    Malpractice may include acts that are normally legal. But they are not called for. It is legal for a doctor to amputate an arm, but it is illegal malpractice if there is no medically valid reason to amputate it.


    If it is shown that IVM has no efficacy and this doctor knew that, then he is guilty of malpractice. If it is shown that in his honest opinion the stuff works, but he happened to be wrong, then he is not guilty. If the stuff works, he knew that, and he is right, then of course he is not guilty.


    Perhaps the Medical Board will exonerate him. I think you should wait and see what it does before condemning the process.

    Quote from Fm1

    This is now 2 studies that show natural immunity is better than vaccination and the first one I posted tells you why!

    And there are many other studies that show the vaccination is better than natural immunity. Apparently, the experts do not know yet.


    There are several other studies that a combination of vaccine plus acquired natural immunity is even better than either one alone.


    What is very clear, and what all the experts agree on, is that in some cases natural immunity has failed. So to be safe anyone who has had COVID should be vaccinated. It may be that the natural immunity works better most of the time, but we know it sometimes fails and the patient becomes severely ill or dies. So why not get both natural and vaccine immunity? Is there any reason why you wouldn't do that? Suspenders and a belt, as I said before.

    Quote from JedRothwell

    Bill Phillips says he made a mistake when he decided not to get the vaccine. He first caught COVID-19 in January 2020 and thought he was immune. A test found he had antibodies against the virus.

    But then, he caught COVID again in June – and ended up spending two months in the hospital. He was intubated for 47 days and didn’t wake up for 18 days.

    Catching Covid in January of 2020 is oddly early. It is also odd that he contracted such a bad case of Covid at a relatively young age and for someone so fit.

    To put it bluntly, it is not an unreasonable possibility that this guy had been taking anabolic steroids. Not judging, just pointing out that there may well be an unspoken part to this story. It's hard for some men who are into hard core training and muscle mass to see that muscle mass wane in their 50s, and so they take a ... proactive approach. But there is a price to be paid!


    How Different Anabolic Steroids Can Affect Your Immune System And Vulnerability To Viral Infections - More Plates More Dates
    Both Testosterone and anabolic androgenic steroids (AAS) adversely influence the immune system, affecting leucocyte growth or activity, and antibody and…
    poddtoppen.se



    In summary, the vast majority of studies suggest that steroid use decreases antibody formation, Natural Killer (NK) lymphocyte activity, T and B lymphocyte maturation and stimulation resulting in immunosuppression [R].

    Supraphysiological doses of common anabolic steroids have been shown to directly influence the production of certain cytokines, altering immune function.

    The results from both animal and human studies suggest that supraphysiological doses of AAS can negatively impact the immune system.

    The takeaway from all of this is that with an easily spread virus infecting thousands of people throughout the world right now, it would be prudent to reduce your exogenous AAS use at least down to therapeutic levels to support immune function during this time where having increased vulnerability to viral infection is the most risky.

    Local health provider claims good results with at-home COVID-19 treatment


    Local health provider claims good results with at-home COVID-19 treatment - KOAM
    It's been well over a year that residents in the 4-states have lived with the pandemic, and only a few treatments have been authorized by the FDA so far. But,…
    www.koamnewsnow.com


    FORT SCOTT, Kan. – In a small family practice in southeast Kansas, a healthcare provider claims to have found a better way.


    “I’ve seen probably close to 50 at this point. Small sample around here,” says Ryan Lewis, a nurse practitioner at Fort Scott Family Medicine.

    Lewis spends his time divided between the military and being a nurse practitioner at the clinic in Fort Scott. He says his military background drove him to find a way to save more lives, especially as nationally authorized treatment options for COVID-19 are slow to come out.


    “I’m not a put myself out there type of person. But when family or friends or people you know die, and it seems like there’s nothing to be done, well,” says Lewis.

    So after reading studies done on several potential treatments for the virus — he now claims to have found an effective regimen for treating COVID-19 symptoms at home.


    “A lot of this at first came from Dr. Peter McCullough down in Texas,” says Lewis.


    When a patient tells him they have tested positive, he does a couple of things. If their symptoms are mild, he tells them to take Famotidine (an over-the-counter antihistamine and antacid), Vitamin C, Vitamin D3, Zinc, Quercetin, Aspirin, and Berberine.

    For moderate symptoms, he has them take the previously mentioned supplements and medications but adds Zpack, Dexamethasone, Hydroxychloroquine, Ivermectin, and Fluvoxamine.


    For severe cases, he adds a nebulizer treatment and/or supplemental oxygen if it’s needed.

    But, several pieces of the protocol are not backed up by the nation’s top disease experts. The National Institutes of Health say there’s not enough data to recommend for or against vitamin C, D3, or Zinc for Covid treatment or prevention. Several of the other medications are the same — with studies ongoing, but more evidence being needed before recommendations are made. However, there are two medications the FDA actively warns against using. The FDA says Ivermectin can interact negatively with other medications, like blood thinners. The biggest danger with Ivermectin comes when large doses are administered, like what is found in farm supply stores.


    The FDA also cautions against using hydroxychloroquine, stating it can cause serious heart rhythm problems and other safety issues. The Emergency Use Authorization for hydroxychloroquine was revoked by the FDA in June because “These medicines showed no benefit for decreasing the likelihood of death or speeding recovery.”


    “From what I have seen, I can’t argue with the results. From what I hear from other providers that have done the same thing with a much larger patient base and had the same results… I can’t argue with that,” explains Lewis. “So, yeah, they say that, but then we also have a brain that we can use and go from there. I looked at all the counter-arguments. I’m very confident at this point… it’s at least something, as opposed to nothing.”


    The FDA has authorized the use of Remdisivir and monoclonal antibodies for the treatment of COVID-19. And recently the FDA gave full authorization to Pfizer’s COVID-19 vaccine for people 16 and older.

    Vitamin C: The NIH states, “There is insufficient evidence for the COVID-19 Treatment Guidelines Panel (the Panel) to recommend either for or against the use of vitamin C for the treatment of COVID-19 in non-critically ill patients… and critically ill patients.”


    Vitamin D3: The NIH states, “There is insufficient evidence to recommend either for or against the use of vitamin D for the prevention or treatment of COVID-19.”


    Zinc: The NIH states, “There is insufficient evidence for the COVID-19 Treatment Guidelines Panel (the Panel) to recommend either for or against the use of zinc for the treatment of COVID-19. The Panel recommends against using zinc supplementation above the recommended dietary allowance for the prevention of COVID-19, except in a clinical trial.” According to the FDA, the recommended dietary daily allowance for zinc supplementation is 11 mg for adults and children aged 4 years and older.


    Aspirin: A study published on the NIH website states, “The authors recommend a low-dose aspirin regimen for primary prevention of arterial thromboembolism in patients aged 40-70 years who are at high atherosclerotic cardiovascular disease risk, or an intermediate risk with a risk-enhancer and have a low risk of bleeding. Aspirin’s protective roles in COVID-19 associated with acute lung injury, vascular thrombosis without previous cardiovascular disease and mortality need further randomized controlled trials to establish causal conclusions.”


    Famotidine: A study published on the NIH website states, “There was no association between incidence of COVID-19 and use of reflux medications, including famotidine at doses used orally to manage reflux and high dose PPIs. Reflux medications did not protect against or increase the risk of COVID-19

    Berberine: A study published on the NIH website states, “As an ingredient recommended in guidelines issued by the China National Health Commission for COVID-19 to be combined with other therapy, berberine is a promising orally administered therapeutic candidate against SARS-CoV and SARS-CoV-2.”


    Quercetin: A study published in the US National Library of Medicine states, “According to the results obtained both in vitro and in vivo, good perspectives have been opened for quercetin. Nevertheless, further studies are needed to better characterize the mechanisms of action underlying the beneficial effects of quercetin on inflammation and immunity.”


    Zpack (AKA Azithromycin). A study published in The Journal of the American Medical Association states, “Among outpatients with SARS-CoV-2 infection, treatment with a single dose of azithromycin compared with placebo did not result in greater likelihood of being symptom free at day 14. These findings do not support the routine use of azithromycin for outpatient SARS-CoV-2 infection.”


    Dexamethasone: The NIH has recommended the use of Dexamethasone, “In hospitalized patients with COVID-19 who require invasive mechanical ventilation or ECMO,” and, “The Panel recommends the use of dexamethasone plus tocilizumab for patients who are within 24 hours of admission to the ICU.” A study in the New England Journal of Medicine also states, “Our results show that among hospitalized patients with Covid-19, the use of dexamethasone for up to 10 days resulted in lower 28-day mortality than usual care in patients who were receiving invasive mechanical ventilation at randomization.”


    Hydroxychloroquine: The FDA actively cautions against using Hydroxychloroquine to treat COVID-19, reporting heart rhythm problems and other serious issues

    Ivermectin: The FDA actively cautions against using Ivermectin, stating, “Even the levels of ivermectin for approved uses can interact with other medications, like blood-thinners. You can also overdose on ivermectin, which can cause nausea, vomiting, diarrhea, hypotension (low blood pressure), allergic reactions (itching and hives), dizziness, ataxia (problems with balance), seizures, coma and even death.”


    Fluvoxamine: Fluvoxamine is a selective serotonin reuptake inhibitor, approved by the FDA as a treatment for OCD, depression and other diseases. The NIH states, “Fluvoxamine is not FDA-approved for the treatment of any infection

    Quote from Alan Fletcher

    Health care care providers were NOT required to make those reports before Covid19 vaccines came out. I'd guess that the most likely 'adult' vaccines pre-covid were influenza, pneumonia, shingles .. ? And most health care providers wouldn't report (eg) Appendicitis for them.

    Where are you getting this information, that health care providers were not required to make VAERS reports before Covid? They have been 'required' to make reports since it was started in 1990, because lawmakers in the Reagan era understood the gravity of the potential consequence of the unprecedented removing of liability from vaccine makers!


    (But the CDC has failed at this responsibility to Congress as well, and VAERS has been, and continues to be, woefully under reporting vaccine adverse events. Doctors are well taught and conditioned to 'know' that vaccines hardly ever cause injury, and so most injuries, if they are reported by patients or parents at all, are seldom reported as possible vaccine injuries by health administrators. )


    Look at a typical WayBack Machine entry from VAERS, this one from October 2019 :


    VAERS - About Us


    Anyone can report an adverse event to VAERS. Healthcare professionals are required to report certain adverse events and vaccine manufacturers are required to report all adverse events that come to their attention.

Subscribe to our newsletter

It's sent once a month, you can unsubscribe at anytime!

View archive of previous newsletters

* indicates required

Your email address will be used to send you email newsletters only. See our Privacy Policy for more information.

Our Partners

Supporting researchers for over 20 years
Want to Advertise or Sponsor LENR Forum?
CLICK HERE to contact us.